The Federal Trade Commission (FTC) Friday, August 2, authorized an action to block Evonik Industries AG’s proposed US$625 million acquisition of PeroxyChem Holding Company, alleging the merger of the chemical companies would substantially reduce competition in the Pacific Northwest and the Southern and Central United States for the production and sale of hydrogen peroxide, a commodity chemical used for oxidation, disinfection, and bleaching.
Featured News
ICE’s $6 Billion MarketAxess Takeover Advances After US Antitrust Clearance
Oct 25, 2026 by
CPI
McCormick’s $44.8 Billion Unilever Food Deal Clears Key US Antitrust Hurdle
Oct 25, 2026 by
CPI
EU Launches Antitrust Probe Into Key Paper-Making Material
Oct 25, 2026 by
CPI
UK Seeks Exemption From EU Technology Rules as Trade Tensions Grow
Oct 25, 2026 by
CPI
Live Nation Reveals Trump Attended White House Antitrust Settlement Meeting
Oct 25, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI
In Praise of Theories of Benefits
Oct 19, 2026 by
Cyril Hariton & Pierre Regibeau
Closing the Efficiencies Gap
Oct 19, 2026 by
Kasia Czapracka & Marika Harjula
Analysis of Dynamic Trade-Offs Under the New Guidelines: Would Cases Like Amazon/Irobot Turn Out Differently?
Oct 19, 2026 by
Oliver Latham, Sam Marden, Saul Mendelsohn & Serge Moresi
Exploitative Portfolio Effects In EU Merger Control: From Mars/Kellanova to the Draft Merger Guidelines
Oct 19, 2026 by
Niels Baeten, Danette Chan & Elizabeth Malik